Medicine and Dentistry
Prostatectomy
100%
Gallium 68
96%
Positron Emission Tomography
96%
Cystoscopy
96%
Prostate Cancer
68%
Biochemical Recurrence
66%
Clinical Decision Making
60%
Diagnosis
57%
Decision Making
57%
Diagnostic Performance
57%
Recurrent Disease
56%
Diffusion MRI
56%
Lymph Node
55%
Transitional Cell Carcinoma
54%
Bladder Cancer
51%
Recurrence Free Survival
51%
Bladder
51%
Systemic Therapy
48%
Prostate Specific Membrane Antigen
48%
Nephroureterectomy
48%
Patient Selection
48%
Cytoreductive Surgery
48%
Biological Marker
48%
Overactive Bladder
48%
Pain Assessment
48%
Nodal Metastasis
48%
Conjugate
39%
Upper Urinary Tract
36%
Neoplasm
32%
Metastatic Carcinoma
24%
Magnetic Resonance Imaging
24%
Cancer Staging
22%
Diseases
20%
Cancer Grading
19%
Proportional Hazards Model
18%
PET-MRI
15%
Diagnostic Accuracy
15%
Radiation Therapy
15%
Histopathology
13%
Prostate Specific Antigen
12%
Risk Stratification
12%
Bootstrapping
12%
Kaplan Meier Method
12%
Recurrence Risk
12%
Gleason Score
12%
Lymph Node Metastasis
12%
Survival Rate
12%
Logistic Regression Analysis
12%
Cross-Validation
12%
Mitomycin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Biochemical Recurrence
96%
Transitional Cell Carcinoma
54%
Recurrence Free Survival
51%
Gallium 68
48%
Polyethylene Terephthalate
48%
Prostate Specific Antigen
32%
Lymph Node Metastasis
32%
Micrometastasis
15%
Recurrence Risk
12%
Cross-Validation
12%
Disease
12%
Survival Rate
12%
Recurrent Disease
8%
Prostate Cancer
8%
Cabazitaxel
8%
